Project Grant HT94252510818
Award Date
9/30/25
Completion Date
9/29/27
Dollars Obligated
$2.6M
Federal Agency
Defense Health Agency
Awardee
Psyonic Inc. (C3GWZTCVJNY7)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92131, USA
Similar Awards
This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
The Defense Health Agency awarded a $2,356,273 project grant to Infinite Biomedical Technologies, LLC (I.b.t.), a minority-owned small business based in Baltimore, Maryland, under the Military Medical Research and Development (CFDA 12.420) program. The grant funding supports research to determine the long-term stability of the glide control strategy for upper limb prostheses. I.b.t. is a specialized medical equipment provider that focuses on developing advanced prosthetic technologies and...
The Defense Health Agency awarded a $1,332,764 Project Grant to Neurocreis, Inc. in College Station, TX under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the "Therapeutic Development of NC101 for Promoting Neurological Recovery After Chronic SCI", with a performance period from July 1, 2025 to June 30, 2028. The funding will enable Neurocreis to conduct advanced biomedical research aimed at transforming healthcare for military service...
The Department of Defense's Defense Health Agency awarded a $1,500,000 Project Grant to the Regents of the University of Michigan to develop "Regenerative Peripheral Nerve Interfaces to Enhance Function and Sensation in People with Transfemoral Amputation" over 4 years, from September 1, 2023 to August 31, 2027. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members...
The federal Project Grant award of $2,477,715.00 from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the Regents of the University of Michigan supports research to develop an exoskeleton control system using a muscle cuff regenerative peripheral nerve interface (MC-RPNI) for restoring lower limb function following traumatic musculoskeletal injury. The project aims to transform healthcare for military service members, veterans, and the broader public...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded The Cleveland Clinic Foundation a $1,448,174 Project Grant on June 1, 2024 to fund research on "INTUITIVE ULTRASOUND-BASED UPPER LIMB PROSTHETIC CONTROL AND FEEDBACK UTILIZING TARGETED REINNERVATION FOR NEUROMA PAIN." The research, conducted in collaboration with the University of California, Davis as a sub-awardee, aims to establish sonomyographic control parameters for patients with...
This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
The Defense Health Agency awarded a $1,401,588 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Roam Robotics Inc. to develop a unilateral powered knee orthosis for knee pain and instability intervention with the VA population. The award period runs from August 1, 2024 to January 31, 2026. Roam Robotics, a for-profit company that provides wearable robotics technologies, will leverage its expertise in exoskeleton systems and active knee assistance devices...
The Defense Health Agency awarded a $490,602 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland. The grant, with a performance period from September 1, 2025 to August 31, 2028, will support the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. EPFL, a non-profit educational institution and state-controlled...